We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Healthcare professionals prescribing montelukast should be alert to the risk of neuropsychiatric reactions in all patients including children and adolescents. Reported neuropsychiatric reactions include sleep disorders, hallucinations, anxiety and depression, as well as changes in behaviour and mood. Healthcare professionals...
Information for clinicians on the characteristics, diagnosis and epidemiology of infections caused by Chlamydia psittaci.
Information on the reasons behind human infectious disease emergence, including a timeline and a global map.
Climate change is happening and is due to human activities; along with warming, many other changes are occurring such as melting polar ice, rising sea levels and more frequent floods, droughts and heatwaves.
Notifications about suspected infectious diseases, collected by the UK Health Security Agency (UKHSA).
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
The surveillance, epidemiology, diagnosis and management of gonorrhoea (Neisseria gonorrhoeae).
How to use a crossover randomised controlled trial to evaluate your digital health product.
This guide is about infections that occur in people who inject drugs (PWID).
The MHRA will introduce a patient alert card to increase awareness among men taking finasteride about potential psychiatric and sexual side effects
Guidance for manufacturers, importers and distributors.
Information for British nationals affected by rape or sexual assault abroad, including how to access medical treatment and legal advice in the UK.
How the MHRA makes decisions on when a product is a medical device (borderline products), and which risk class should apply to a medical device.
Advice for people returning to the UK after working in an Ebola or Marburg virus affected area.
Information for health professionals on the characteristics, diagnosis and treatment of Pontiac fever.
How to show MHRA you're meeting good clinical practice (GCP) standards and what to expect from an inspection.
This document explains: how patients are tested and treated, and steps in place to prevent its spread.
A patient alert card is being introduced for men taking finasteride to help raise awareness of the risk of psychiatric side effects and sexual dysfunction, including the potential for sexual dysfunction to persist after treatment has stopped. Healthcare professionals are...
Guidance relating to blood clotting, myocarditis and Guillain-Barré Syndrome (GBS) after COVID-19 vaccination.
The characteristics, transmission and management of head lice (pediculosis).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.